Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts

FDA Drug Recalls

18 recalls, newest first

Class II · Moderate risk

Tacrolimus Capsules

Presence of Foreign Tablets/Capsules: One 0.5 mg Tacrolimus capsule found in a bottle of 1 mg Tacrolimus capsules.

Terminated Particulate / foreign matter Dr. Reddy's Laboratories, Inc. NDC 55111-526-01 D-0219-2024
Class III · Low risk

Lisinopril Tablets USP 20 mg

Presence of Foreign Tablets: Potential of stray tablet(s) of Amlodipine Besylate 10 mg Tablet within the recalled lots

Terminated Particulate / foreign matter NCS Healthcare of Kentucky Inc NDC 0615-7718-05 D-0114-2024
Class II · Moderate risk

Montelukast Sodium Tablets

Presence of Foreign Tablet(s)/Capsule(s): A foreign tablet was found in a bottle of Montelukast Sodium Tablets, USP 10mg, identified as metoprolol 25 mg.

Terminated Particulate / foreign matter Dr. Reddy's Laboratories, Inc. NDC 55111-725-10 D-0086-2024
Class I · High risk

Betaxolol Tablets

Presence of Foreign Tablets/Capsules: There is a potential presence of oxycodone HCl tablets, USP 5 mg in bottles.

Terminated Particulate / foreign matter KVK-Tech, Inc. NDC 10702-013-01 D-0049-2024
Class III · Low risk

Gabapentin Tablets

Presence of Foreign Tablets/Capsules: Pharmacist reported presence of some Gabapentin tablets 800 mg comingled in Gabapentin 600 mg 500 count bottles.

Terminated Particulate / foreign matter Sciegen Pharmaceuticals Inc D-0354-2023
Class II · Moderate risk

Allopurinol Tablets 100mg

Presence of Foreign Substance: manufacturer recalled this re-packaged product due to reports of a small piece of green plastic embedded in the crack towards the edge of the tablet.

Terminated Particulate / foreign matter Preferred Pharmaceuticals, Inc. D-0173-2023
Class II · Moderate risk

Allopurinol Tablets USP

Presence of Foreign Substance: Presence of a small piece of green plastic embedded in the crack towards the edge of the tablet.

Terminated Particulate / foreign matter Accord Healthcare, Inc. NDC 16729-134-01 D-0168-2023

Recalls by year